Dräger participates in High-Tech Gründerfonds (HTGF) III
Lübeck/ Bonn - Dräger participates in HTGF III, Europe’s most active early-stage investor, which includes the German Federal Ministry for Economic Affairs and Energy, KfW, the Fraunhofer-Gesellschaft e.V. and renowned business enterprises from all sectors and disciplines. HTGF has been a strong driver of successful high-tech startups since 2005, providing industry with early access to startups and technology trends.
Christoph Schweizer, Head of Corporate Strategy & Business Development at Dräger: “The investment in HTGF III is an important building block for Dräger to further expand our technological competencies in a targeted manner and thus supports our activities for the development of new business models. Through HTGF’s network and the seat on the investment committee, we have the opportunity to identify interesting developments and promising startup companies at an early stage and to participate in them.”
Steffen Müller, Head of Mergers & Acquisitions / New Business Development at Dräger, adds: “By cooperating with agile startups, we want to significantly strengthen our innovative power. Dräger’s in-depth knowledge of customer requirements and regulations in the fields of medical and safety technology will help to drive the young companies’ development projects forward in a targeted and efficient manner during the collaboration.”
Dr. Michael Brandkamp, Managing Director of HTGF confirms: “Dräger is a company with a long tradition, experience and know-how in the key sectors of medical and safety technology. We are very much looking forward to the collaboration and see great potential for cooperation with our portfolio.”
In April 2017, Dräger already acquired the majority shares in the Hamburg-based bentekk GmbH, which was seed-financed by HTGF. “The sale of bentekk to Dräger has already established a very good relationship between Dräger and HTGF. I am convinced that we will have many more points of contact with our portfolio,” adds Dr. Alex von Frankenberg, Managing Director of HTGF.
HTGF invests openly across all sectors and is intensively networked with all players in the startup and investor scene. This is precisely what guarantees the success of the portfolio companies and sustainably strengthens Germany as a location for start-ups and business.
The seed investor High-Tech Gründerfonds (HTGF) finances technology startups with growth potential. With a total volume of 886 million euros distributed across three funds (272 million euros Fund I, 304 million euros Fund II, target: 310 million euros Fund III), as well as an international partner network, HTGF has already shaped nearly 500 startups into companies since 2005. Its team of experienced investment managers and startup experts focuses on high-tech startups in the software, media and Internet sectors, as well as hardware, automation, healthcare, chemicals and life sciences.
Investors in the public-private partnership include. the German Federal Ministry for Economic Affairs and Energy, KfW, the Fraunhofer-Gesellschaft and the business enterprises ALTANA, BASF, B.Braun, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik and WACKER.
Dräger is a leading international medical and safety technology company. Dräger products protect, support and save lives. Founded in 1889, Dräger generated sales of over EUR 2.5 billion in 2016. The Lübeck-based company is represented worldwide and employs more than 13,000 people. www.draeger.com